N-acetyl-L-cysteine (NAC)

DRUG3 trials

Sponsors

Peking University People's Hospital, Immunoflex Therapeutics Inc.

Conditions

Acute Myeloid Leukemia, AdultImmunity DisordersStem Cell Transplant ComplicationsThrombocytopenia

Phase 2

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

TerminatedNCT03391856

Peking University People's HospitalStem Cell Transplant Complications, Thrombocytopenia

Start: 2018-03-01End: 2018-12-30Updated: 2020-09-25

Unknown Phase

Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants

CompletedNCT05242718

Immunoflex Therapeutics Inc.Immunity Disorders

Start: 2021-01-10End: 2021-05-20Updated: 2022-02-16

NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled Study

Not yet recruitingNCT07869342

Peking University People's HospitalAcute Myeloid Leukemia, Adult

Start: 2026-10-01End: 2029-12-31Target: 180Updated: 2026-10-09